Skip to main content

Agilent Completes $4.5 Billion Stock Buyback Ahead of Schedule

NEW YORK, June 22 (GenomeWeb News) - Agilent Technologies has completed its $4.5 billion stock repurchase program ahead of schedule, the company said today.

 

Agilent acquired approximately 125 million shares of its common stock under the program. Agilent expects to report approximately 430 million average shares outstanding on a fully diluted basis during its third quarter ending July 30.

 

Agilent's board of directors authorized the buyback program on Aug. 15, 2005, along with the sale of its semiconductor-related business. The buyback was projected to complete by the end of this year.

 

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.